← Leaderboards
Carlos Cordon-Cardo
Sloan-Kettering Institute For Cancer Res
$7,210,529
Attributed
$7,210,529
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $723.8K · FY2006–15$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$7,210,529 · 7
By mechanism
P01$6,586,057 · 6
P50$624,472 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Institute For Cancer Res
Same institution · by research overlap
- Andrew Koff$7,486,650
- Richard J O'Reilly$17,498,839
- Glenn Heller$7,155,475
- Scott Keeney$13,639,540
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsMolecularTumor ProgressionTumorBaseGenesMutationSenescencePatternSamplingMutantReportingGene ExpressionClinically SignificantBiologicalGeneticLinkEventDna DamageApoptosisSmall Hairpin RnaClinically RelevantAffectGene Targeting
Grant awards (25)
Molecular Studies of the p53 Pathway in Human Cancer$444,564
P01 · FY2015 · CA · contact PI
Molecular Systems Pathology Core$178,077
P01 · FY2015 · CA · contact PI
Molecular Studies of the p53 Pathway in Human Cancer$433,061
P01 · FY2014 · CA · contact PI
Molecular Systems Pathology Core$170,922
P01 · FY2014 · CA · contact PI
Molecular Studies of the p53 Pathway in Human Cancer$421,579
P01 · FY2013 · CA · contact PI
Molecular Systems Pathology Core$163,731
P01 · FY2013 · CA · contact PI
Molecular Studies of the p53 Pathway in Human Cancer$450,278
P01 · FY2012 · CA · contact PI
Molecular Systems Pathology Core$180,472
P01 · FY2012 · CA · contact PI
Molecular Studies of the p53 Pathway in Human Cancer$410,358
P01 · FY2010 · CA · contact PI
Molecular Analysis of Proliferative and Apoptotic Pathways in Soft Tissue Sarcoma$313,457
P01 · FY2010 · CA · contact PI
Molecular Studies of the p53 Pathway in Human Cancer$404,960
P01 · FY2009 · CA · contact PI
Molecular Analysis of Proliferative and Apoptotic Pathways in Soft Tissue Sarcoma$308,254
P01 · FY2009 · CA · contact PI
Molecular Studies of the p53 Pathway in Human Cancer$395,814
P01 · FY2008 · CA · contact PI
Molecular Analysis of Proliferative and Apoptotic Pathways in Soft Tissue Sarcoma$300,220
P01 · FY2008 · CA · contact PI
Molecular Studies of the p53 Pathway in Human Cancer$416,746
P01 · FY2007 · CA · contact PI
Molecular Analysis of Proliferative and Apoptotic Pathways in Soft Tissue Sarcoma$298,204
P01 · FY2007 · CA · contact PI
Molecular Studies of the p53 Pathway in Human Cancer$361,837
P01 · FY2006 · CA · contact PI
Molecular Analysis of Proliferative and Apoptotic Pathways in Soft Tissue Sarcoma$133,801
P01 · FY2006 · CA · contact PI
Histopathology and Molecular Pathology$107,829
P01 · FY2006 · CA · contact PI
CYCLIN DEPENDENT KINASE INHIBITORS IN BENIGN AND MALIGNANT PROSTATIC DISEASES$233,892
P50 · FY2002 · DK
FUNCTIONAL AND IMMUNOPHENOTYPIC ANALYSIS OF P53 AND RB$230,631
P01 · FY2002 · CA
CYCLIN DEPENDENT KINASE INHIBITORS IN BENIGN AND MALIGNANT PROSTATIC DISEASES$233,892
P50 · FY2001 · DK
FUNCTIONAL AND IMMUNOPHENOTYPIC ANALYSIS OF P53 AND RB$230,631
P01 · FY2001 · CA
FUNCTIONAL AND IMMUNOPHENOTYPIC ANALYSIS OF P53 AND RB$230,631
P01 · FY2000 · CA
CYCLIN DEPENDENT KINASE INHIBITORS IN BENIGN AND MALIGNANT PROSTATIC DISEASES$156,688
P50 · FY2000 · DK